Neurology
Webinar 2: Drug Resistant Epilepsy: Approach to Management in 2024
This course explores the diagnosis and management of drug-resistant epilepsy (DRE), emphasizing second- and third-generation anti-seizure medications, genetic considerations, and targeted treatments. Participants will also learn about alternative therapies, including dietary approaches, surgery, and neurostimulation, and the unique challenges of transitioning care from paediatric to adult services. This program equips healthcare professionals with strategies to enhance outcomes for individuals with DRE.
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
MOC - Section 1
EXPIRY DATE
2025-11-27
This course explores the diagnosis and management of drug-resistant epilepsy (DRE), emphasizing second- and third-generation anti-seizure medications, genetic considerations, and targeted treatments. Participants will also learn about alternative therapies, including dietary approaches, surgery, and neurostimulation, and the unique challenges of transitioning care from paediatric to adult services. This program equips healthcare professionals with strategies to enhance outcomes for individuals with DRE.
This program has received an unrestricted educational grant or in-kind support from Paladin Pharma Inc.
Faculty
Moderator:
Anita Datta, MD
Panelist:
Mary Connolly, MB BCh, FRCPC, FRCPI, FRCP(Edin), FAES
Learning objectives
After completion of the webinar participants will be better able to:
- Summarize the advances in anti-seizure medications, dietary therapy, epilepsy surgery, neuromodulation and precision medicine
- Describe comorbidities and issues beyond seizures
- Support transition to adult services for those with pediatric onset epilepsy
- Describe challenges in epilepsy care
Accreditation
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of General Surgeons. You may claim a maximum of 1 hour per webinar.
# of credits: 1 
Duration: 1 hr FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Specialist
Profession
1
# of credits
Learning Objectives
After completion of the webinar participants will be better able to:
- Summarize the advances in anti-seizure medications, dietary therapy, epilepsy surgery, neuromodulation and precision medicine
- Describe comorbidities and issues beyond seizures
- Support transition to adult services for those with pediatric onset epilepsy
- Describe challenges in epilepsy care
MOC - Section 1
ACCREDITATION
Neurology
Learning Category
Epilepsy
Topic
0
Price
2025-11-27
Expiry Date
CAN-eng
Region/Language
Course Description
This course explores the diagnosis and management of drug-resistant epilepsy (DRE), emphasizing second- and third-generation anti-seizure medications, genetic considerations, and targeted treatments. Participants will also learn about alternative therapies, including dietary approaches, surgery, and neurostimulation, and the unique challenges of transitioning care from paediatric to adult services. This program equips healthcare professionals with strategies to enhance outcomes for individuals with DRE.
This program has received an unrestricted educational grant or in-kind support from Paladin Pharma Inc.
Faculty
Moderator:
Anita Datta, MD
Panelist:
Mary Connolly, MB BCh, FRCPC, FRCPI, FRCP(Edin), FAES
Accreditation
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of General Surgeons. You may claim a maximum of 1 hour per webinar.
1 hr
Duration
0
Price
1
# of credits
